L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI)
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Basic information
- Product Name:
- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI)
- Synonyms:
-
- Eptifibatide Impurity 19
- Eptifibatide Impurity 13
- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI)
- CAS:
- 868242-25-5
- MF:
- C37H52N12O10S2
- MW:
- 889.02
- Mol File:
- 868242-25-5.mol
More
Less
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Chemical Properties
- Density
- 1.60±0.1 g/cm3(Predicted)
- pka
- 4.01±0.10(Predicted)
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI)Supplier
Shanghai Kewel Chemical Co., Ltd.
- Tel
- 021-64609169 18901607656
- greensnown@163.com
Hubei Yangxin Medical Technology Co., Ltd.
- Tel
- 15374522761
- 3003392093@qq.com
Nanjing Huanuo Biomedical Technology Co., Ltd
- Tel
- 18913906212
- 2885426135@qq.com
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
- Tel
- 18162595016; 18162595016
- 3287908757@qq.com
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd
- Tel
- 18102736234 18102736234
- 2208093734@qq.com
More
Less
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI)(868242-25-5)Related Product Information
- L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI)
- Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo
- Cyclo(L-Pro-L-Trp-)
- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide)
- N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide
- Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]-
- Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)-
- Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)-
- 7-Bromo Epinastine
- Eptifibatide non cyclic impurity
- 3'-Hydroxyacetophenone
- 6-Chloromethylmorphanthridine
- Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-